MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/febs.17380

Медицинская библиотека · The FEBS journal · 2025

Psoralidin acts as a dual protease inhibitor against PLpro and Mpro of SARS-CoV-2.

Trivedi Aditya, Kushwaha Tushar, Ishani, Vrati Sudhanshu, Gupta Dharmender, Kayampeta Sarala Rani, Parvez Mohammad Khalid, Inampudi Krishna Kishore, Appaiahgari Mohan Babu, Sehgal Deepak

СтатьяПеревод пока не подготовлен

Аннотация

The emergence of new coronavirus variants and concerns about vaccine effectiveness against these novel variants emphasize the need for broad-spectrum therapeutics targeting conserved coronaviral non-structural proteins. Accordingly, a virtual library of 178 putative inhibitors targeting SARS-CoV-2 Papain-like protease (PLpro) was compiled through a systematic review of published literature and subsequently screened using molecular docking. Selected hits were analyzed for protease inhibitory activities, binding strength, and antiviral activities against HCoV229E-based surrogate system and subsequently against SARS-CoV-2 for validation. Differences in potential modes of action were investigated using an HCoV229E-based system, combined with in silico and biophysical methods against SARS-CoV-2 system. Of the 178 hits, 13 molecules showed superior docking scores against PLpro and met the inclusion criteria for further investigations. Of these, seven showed notable inhibitory activities against PLpro. Particularly, both Psoralidin and Corylifol-A exhibited superior and, importantly, dual activities against SARS-CoV-2 Mpro. Both molecules were found to be biologically active against HCoV229E and SARS-CoV-2; however, Psoralidin exhibited more consistent effects and was relatively well-tolerated. Detailed in silico analyses of their interactions with the two proteases identified differences in their modes of action, primarily due to differences in their binding of PLpro. Based on these findings, we propose Psoralidin as a potential candidate for further development as a broad-spectrum antiviral and Corylifol-A as an ideal candidate for lead optimization.

Для цитирования: Trivedi Aditya, Kushwaha Tushar, Ishani, Vrati Sudhanshu, Gupta Dharmender, Kayampeta Sarala Rani, Parvez Mohammad Khalid, Inampudi Krishna Kishore, Appaiahgari Mohan Babu, Sehgal Deepak. Psoralidin acts as a dual protease inhibitor against PLpro and Mpro of SARS-CoV-2.. The FEBS journal. 2025. DOI: 10.1111/febs.17380.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.